Split history for Teva- Pharmaceutical Industries Ltd. - ADR
Teva- Pharmaceutical Industries Ltd. - ADR has split the face value 5 times since Aug. 16, 1982. Teva- Pharmaceutical Industries Ltd. - ADR had last split the face value of its shares from $2 to $1 in 2004.The share has been quoting on an ex-split basis from July 1, 2004.
| Split Date | Split Ratio |
|---|---|
| 01 Jul 2004 | 2:1 Stock split |
| 06 Dec 2002 | 2:1 Stock split |
| 23 Feb 2000 | 2:1 Stock split |
| 14 Apr 1993 | 2:1 Stock split |
| 16 Aug 1982 | 1:1 Stock split |
Dividend history for Teva- Pharmaceutical Industries Ltd. - ADR
Teva- Pharmaceutical Industries Ltd. - ADR has declared 75 dividends since May 19, 1992.
| Ex-Date | Dividend Amount | Instrument Type |
|---|---|---|
| 01 Jun 2017 | 0.34 | Equity Share |
| 28 Feb 2017 | 0.34 | Equity Share |
| 01 Dec 2016 | 0.34 | Equity Share |
| 18 Aug 2016 | 0.34 | Equity Share |
| 20 May 2016 | 0.34 | Equity Share |
| 25 Feb 2016 | 0.34 | Equity Share |
| 13 Nov 2015 | 0.34 | Equity Share |
| 18 Aug 2015 | 0.34 | Equity Share |
| 15 May 2015 | 0.34 | Equity Share |
| 17 Feb 2015 | 0.34 | Equity Share |
| 13 Nov 2014 | 0.32 | Equity Share |
| 19 Aug 2014 | 0.35 | Equity Share |
| 16 May 2014 | 0.35 | Equity Share |
| 20 Feb 2014 | 0.34 | Equity Share |
VIEW MORE
Board Meetings - Teva- Pharmaceutical Industries Ltd. - ADR
The next board meeting for Teva- Pharmaceutical Industries Ltd. - ADR is on 08 May 2025 for the purpose of Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call for 2025
| Ex-Date | Purpose | Notes |
|---|---|---|
| 06 Jun 2025 | Teva Pharmaceutical Industries Ltd Annual General Meeting for 2025 | - |
| 08 May 2025 | Teva Pharmaceutical Industries Ltd First Quarter Earnings Results for 2025 | - |
| 08 May 2025 | Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call for 2025 | - |
| 12 Mar 2025 | Leerink Partners Global Healthcare Conference | - |
| 11 Mar 2025 | Barclays 27th Annual Global Healthcare Conference | - |
| 24 Feb 2025 | Duvakitug (Anti-TL1A) Phase 2b data presentation from ECCO – Conference call | - |
| 12 Feb 2025 | Teva Pharmaceutical Industries Ltd Annual Report for 2024 | - |
| 05 Feb 2025 | Teva Pharmaceutical Industries Ltd Annual Report for 2024 | - |
| 31 Jan 2025 | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call for 2024 | - |
| 31 Jan 2025 | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Results for 2024 | - |